May 24th 2022 The many standards by which we navigate our daily lives are never established by caprice or whim, […]
May 12, 2022 A well-intentioned but ineffective proposal that would force drug manufacturers to post the price of prescription […]
May 11, 2022 Dear Senate Leaders, In spite of well-founded fears about the safety and effectiveness of allowing states to […]
MaY 9, 2022 Over the past year, President Biden and Senate Democrats have endorsed a proposal that would radically […]
May 5, 2022 There’s a slow-motion train wreck unfolding for U.S. consumers. Inflation is on the rise — and is […]
https://bit.ly/3xAYVpP by Gerard Scimeca, CASE Chairman April 18, 2022 The music industry has recently come under significant antitrust scrutiny. […]
April 15, 2022 Heading into the midterm elections, consumer confidence in the economy is at its lowest point since the financial […]
April 13, 2022 It would seem that any policy innovation that could lower healthcare costs, expand access, provide better care, […]
April 12, 2022 Pandemic or not, millions of Americans heavily depend on lifesaving treatments. Thanks to America’s cutting-edge healthcare system […]
April 6, 2022 A little-known federal agency is hatching big plans that could impact millions of consumers across the […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/